Chemed Corporation $CHE Position Raised by Clifford Capital Partners LLC

Clifford Capital Partners LLC grew its stake in Chemed Corporation (NYSE:CHE) by 5,818.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 46,990 shares of the company’s stock after purchasing an additional 46,196 shares during the period. Chemed makes up about 3.6% of Clifford Capital Partners LLC’s portfolio, making the stock its 10th biggest position. Clifford Capital Partners LLC owned about 0.33% of Chemed worth $21,039,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Alps Advisors Inc. lifted its position in Chemed by 32.4% in the third quarter. Alps Advisors Inc. now owns 44,295 shares of the company’s stock worth $19,833,000 after buying an additional 10,845 shares during the last quarter. Vest Financial LLC increased its position in Chemed by 32.6% during the third quarter. Vest Financial LLC now owns 9,702 shares of the company’s stock valued at $4,344,000 after acquiring an additional 2,383 shares during the last quarter. Envestnet Asset Management Inc. increased its position in Chemed by 6.5% during the third quarter. Envestnet Asset Management Inc. now owns 80,080 shares of the company’s stock valued at $35,855,000 after acquiring an additional 4,865 shares during the last quarter. Van Berkom & Associates Inc. raised its stake in shares of Chemed by 33.0% in the third quarter. Van Berkom & Associates Inc. now owns 170,813 shares of the company’s stock valued at $76,480,000 after acquiring an additional 42,390 shares during the period. Finally, Fenimore Asset Management Inc raised its stake in shares of Chemed by 28.3% in the third quarter. Fenimore Asset Management Inc now owns 37,240 shares of the company’s stock valued at $16,674,000 after acquiring an additional 8,222 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

Chemed stock opened at $402.03 on Friday. The company has a market capitalization of $5.54 billion, a PE ratio of 21.89, a P/E/G ratio of 1.59 and a beta of 0.46. The company has a 50 day moving average price of $441.48 and a 200-day moving average price of $440.92. Chemed Corporation has a fifty-two week low of $385.00 and a fifty-two week high of $623.60.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.02 by ($0.60). The firm had revenue of $639.34 million during the quarter, compared to the consensus estimate of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.The firm’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period last year, the company earned $6.83 EPS. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, analysts forecast that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were paid a dividend of $0.60 per share. The ex-dividend date was Monday, February 23rd. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is currently 13.06%.

Analyst Ratings Changes

CHE has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Oppenheimer cut their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $422.00 price objective (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Finally, Zacks Research cut Chemed from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 4th. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Chemed presently has an average rating of “Hold” and an average target price of $498.00.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $403.18, for a total value of $806,360.00. Following the completion of the sale, the chief executive officer directly owned 93,719 shares in the company, valued at $37,785,626.42. The trade was a 2.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 3.29% of the stock is owned by insiders.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.